In the context of prostate cancer, the overexpression of EEF1A2 in metastatic prostate cancer suggests its potential as a tissue-based biomarker for monitoring cancer progression and cell transformation [19]. The gene discussed is EEF1A2; the disease is metastatic prostate carcinoma.